For 30 years, Urologic Clinics of North America has provided important clinical updates on the entire spectrum of urology. Each quarterly issue (February, May, August, and November) focuses on a specific topic, with review articles written by leading experts in the field. Topics include adult and pediatric clinical urology, as well as surgical oncology, radiology, pathology, erectile dysfunction, infertility, incontinence, transplantation, endourology, andrology, female urology, reconstructive surgery, and medical oncology. In addition, you can also purchase a CME subscription that offers up to 60 AMA Category 1 credits per year.
Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. The journal publishes practical, timely, and relevant clinical and basic science research articles which address any aspect of urologic oncology. Each issue comprises original research, news and topics, survey articles providing short commentaries on other important articles in the urologic oncology literature, and reviews including an in-depth Seminar examining a specific clinical dilemma. The journal periodically publishes supplement issues devoted to areas of current interest to the urologic oncology community. Articles published are of interest to researchers and the clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
The mission of Urology®, the "Gold Journal," is to provide practical, timely, and relevant clinical and basic science information to physicians and researchers practicing the art of urology worldwide. Urology® publishes original articles relating to adult and pediatric clinical urology as well as to clinical and basic science research. Topics in Urology® include pediatrics, surgical oncology, radiology, pathology, erectile dysfunction, infertility, incontinence, transplantation, endourology, andrology, female urology, reconstructive surgery, and medical oncology, as well as relevant basic science issues. Special features include rapid communication of important timely issues, surgeon's workshops, interesting case reports, surgical techniques, clinical and basic science review articles, guest editorials, letters to the editor, book reviews, and historical articles in urology.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Urology Case Reports is an open access journal dedicated to publishing case reports in all areas of adult and pediatric urology. Case reports must be authentic, understandable, educational, and clinically interesting to an international audience of practicing urologists, trainees, and researchers.All case reports submitted are peer reviewed and if accepted for publication, authors are notified of the decision and requested to pay an Article Processing Fee of $600. Following payment of this fee, the article is made universally available to all on www.sciencedirect.com and www.urologycasereports.com.Urology Case Reports will be indexed in SCOPUS and Google Scholar.
Original work published in
Members of the American Urological Association may access Urology Practice online by logging in at
Utilities Policy is the peer-reviewed journal for researchers, utility company professionals, financial analysts, and industry consultants. It publishes original research papers, review papers, viewpoints, as well as book reviews, about the entire range of utilities including coal, electricity, gas, oil, telecommunications, urban transport, water, waste, and renewable forms of energy.Utilities Policy is a unique international journal covering economic, development, environmental, institutional, legal, liberalization, management, organisation, performance, planning, policy, pricing, privatization, regulation, and strategic issues across the broad spectrum of utilities. The journal addresses utilities in developed and developing countries, and offers a leading forum for the dissemination of in-depth analysis of key trends to those concerned with the effective management and development of utilities.Submissions should consider the policy implications of the subject being written about. Specific policy-related suggestions, if relevant, are encouraged so as to provide policy makers firm ideas to consider for implementation. Utilities Policy welcomes submissions that assess and compare methodologies and novel approaches relating to two or more utility sectors.
Vaccine is the journal for those interested in vaccines and vaccination. Submissions to the following categories are welcomed: Human Vaccines - infectious diseases; Human Vaccines - non-infectious diseases; Veterinary Vaccines; Immunology and Animal Models; Vectors, Adjuvants and Delivery Systems; Production, manufacturing; Vaccine Safety; Regulatory, Societal and Legislation Aspects; History of Vaccinology.
Vaccine: X is the open access mirror journal of Vaccine.
Vaccine: X offers authors with high-quality research who want to publish in a gold open access journal the opportunity to make their work immediately, permanently, and freely accessible.
Vaccine: X authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright.
Vaccine and Vaccine: X have the same aims and scope. A unified editorial team manages rigorous peer-review for both titles using the same submission system. The author's choice of journal is blinded to referees, ensuring the editorial process is identical.
Sin duda una de las mejores publicaciones para conocer los avances en el campo de las vacunaciones preventivas, tanto en el ámbito de la investigación básica como aplicada y en la evaluación de programas de vacunaciones. Su alta calidad y utilidad la ha llevado a estar indexada en los prestigiosos índices IME y SCOPUS.4 NÚMEROS AL AÑOPara más información, consulte http://www.elsevier.es/vac
Vacuum is an international rapid publications journal with a focus on short communication. All papers are peer-reviewed, with the review process for short communication geared towards very fast turnaround times. The journal also published full research papers, thematic issues and selected papers from leading conferences.A report in Vacuum should represent a major advance in an area that involves a controlled environment at pressures of one atmosphere or below.The scope of the journal includes:1. Vacuum; original developments in vacuum pumping and instrumentation, vacuum measurement, vacuum gas dynamics, gas-surface interactions, surface treatment for UHV applications and low outgassing, vacuum melting and sintering. Technology and solutions for large-scale facilities (e.g., particle accelerators and fusion devices). New instrumentation ( e.g., detectors and electron microscopes). 2. Plasma science; advances in PVD, CVD, plasma-assisted CVD, ion sources, deposition processes and analysis.3. Surface science; surface engineering, surface chemistry, surface analysis, crystal growth, ion-surface interactions and etching, nanometer-scale processing, surface modification.4. Materials science; novel functional or structural materials. Metals, ceramics, and polymers. Experiments, simulations, and modelling for understanding structure-property relationships. Thin films and coatings. Nanostructures and ion implantation.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Value in Health contains original research articles for pharmacoeconomics, health economics, and outcomes research (clinical, economic, and patient-reported outcomes/preference-based research), as well as conceptual and health policy articles that provide valuable information for health care decision-makers as well as the research community. As the official journal of ISPOR, Value in Health provides a forum for researchers, as well as health care decision-makers to translate outcomes research into health care decisions.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Value in Health Regional Issues (ViHRI) is a new scientific journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) to encourage and enhance the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions in Asia, Latin America, Central & Eastern Europe, Western Asia, and Africa.
Vascular Diseases (formerly JMV- Journal de Médecine Vasculaire) publishes peer-reviewed clinical and research articles, reviews articles, epidemiological studies, guidelines, consensus statements, and this in all areas of vascular diseases.
The journal also publishes abstracts of papers presented at the annual sessions of the national congress of French College of Vascular Pathology.
Vascular Pharmacology publishes papers, which contains results of all aspects of biology and pharmacology of the vascular system.Papers are encouraged in basic, translational and clinical aspects of Vascular Biology and Pharmacology, utilizing approaches ranging from molecular biology to integrative physiology. All papers are in English.The Journal publishes review articles which include vascular aspects of thrombosis, inflammation, cell signalling, atherosclerosis, and lipid metabolism.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com